Evaluation of Pfizer-BioNTech COVID-19 vaccine among residents of two skilled nursing facilities
The severity of COVID-19 among the residents of long-term care facilities (LTCFs) has been reported to be disproportionately high. Specifically, individuals residing in skilled nursing facilities (SNFs) are found to be the most severely affected, both in terms of morbidity and mortality, and are, thereby, listed for early COVID-19 vaccination. In comparison to the general population, SNF residents are more vulnerable, with a weak immune system.
LTCFs and SNFs were not included in the clinical trials of COVID-19 vaccines. This resulted in a limitation, i.e., minimal data to determine the vaccine effectiveness (VE) for this vulnerable group. Additionally, in the case of the Pfizer-BioNTech vaccine, the immunogenicity was found to be lower in the age group between 65–85 years. However, for the younger population, the vaccine was found to be more efficient.
Brookdale Completes Second Round Of Vaccine Clinics At All Communities
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Brookdale Completes Second Round Of Vaccine Clinics At All Communities
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.